Increasingly complex clinical trials are putting pressure on CROs to expand their service offerings in what has been a historically monolithic space – with diagnostics also continuing to play a more important role in the market, says industry expert.
BlueCloud by HealthCarePoint releases DDIT mechanisms to create an Uber-like service for the health care industry – connecting providers and consumers, such a sponsors and CROs.
CRO stock prices fell initially following the news that Bristol-Myers Squibb was acquiring Celgene in a deal valued at $74bn. However, is 2019’s first mega-merger really a threat to service providers?